Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperosmolar dextrose injection for Osgood-Schlatter disease
jRCT1091220236Completed
- Sponsor
- Kanazawa University Hospital
- Start
- Jan 2016
- Countries
- 1
01
Overview
Randomised, double-blind trial of dextrose in Osgood-Schlatter disease (OSD) (2 arms), sponsored by Kanazawa University Hospital. Primary endpoint: VISA score at final follow-up. Started Jan 2016; status: completed.
02
Drugs
dextrose
03
Conditions
Osgood-Schlatter disease (OSD)
Beyond the preview
Go deeper on jRCT1091220236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220236.